Keybank National Association OH Sells 3,223 Shares of Intuitive Surgical, Inc. $ISRG

Keybank National Association OH lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 75,431 shares of the medical equipment provider’s stock after selling 3,223 shares during the quarter. Keybank National Association OH’s holdings in Intuitive Surgical were worth $30,673,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Bank of America Corp DE grew its holdings in Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after buying an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in Intuitive Surgical in the 2nd quarter valued at $1,335,753,000. Amundi lifted its stake in Intuitive Surgical by 8.6% during the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after acquiring an additional 193,096 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after acquiring an additional 1,027,475 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. lifted its stake in Intuitive Surgical by 10.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after acquiring an additional 184,044 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Mark Brosius sold 61 shares of the stock in a transaction on Wednesday, October 28th. The stock was sold at an average price of $441.60, for a total transaction of $26,937.60. Following the completion of the transaction, the executive vice president owned 581 shares in the company, valued at approximately $256,569.60. This represents a 9.50% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $457.34, for a total value of $4,573,400.00. Following the transaction, the director owned 1,194,530 shares of the company’s stock, valued at $546,306,350.20. The trade was a 0.83% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 39,056 shares of company stock valued at $17,585,864. Company insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on ISRG shares. BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a research note on Tuesday, July 28th. Barclays reiterated an “overweight” rating and issued a $500.00 target price (up from $485.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. Wells Fargo & Company reissued an “overweight” rating and set a $486.00 price target (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Piper Sandler restated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. Finally, BTIG Research reaffirmed a “buy” rating and issued a $454.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $493.54.

Intuitive Surgical Stock Down 0.1%

Shares of ISRG stock opened at $449.53 on Thursday. The company has a 50 day moving average of $414.76 and a 200-day moving average of $430.83. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The firm has a market cap of $155.83 billion, a P/E ratio of 54.36, a PEG ratio of 3.10 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the prior year, the business earned $2.40 earnings per share. Intuitive Surgical’s revenue for the quarter was up 21.7% on a year-over-year basis. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.